Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

OBJECTIVE: Intravenous iron is widely used to treat iron deficiency in day-care units. Ferric carboxymaltose (FCM) allows administration of larger iron doses than iron sucrose (IS) in each infusion (1000 mg vs. 200 mg). As FCM reduces the number of infusions required but is more expensive, we perfor...

Full description

Bibliographic Details
Main Authors: Xavier Calvet, Miquel Àngel Ruíz, Angelina Dosal, Laura Moreno, Maria López, Ariadna Figuerola, David Suarez, Mireia Miquel, Albert Villoria, Emili Gené
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3448662?pdf=render

Similar Items

Similar Items